Microbiome Therapeutics Pipeline

Pipeline
Indication
Discovery
Preclinical
Clinical Development
Phase1
Phase2
Phase3
LABTHERA-001
Bacterial Vaginosis
LABTHERA-002
Adjunctive Therapy with Cytotoxic Chemotherapy
LABTHERA-004
Allergic Diseases
LABTHERA-005
Inflammatory Diseases
LABTHERA-006
Metabolic Dysfunction–Associated Steatohepatitis (MASH)